Documentation pain management groups typically request first
Pain management and physical medicine groups that bring in a new tissue or exosome supplier commonly start by asking for the same records a compliance officer would want on file: a donor eligibility and screening summary, a certificate of analysis tied to a specific lot, and a description of how the product was processed and tested before release. Group practices that operate across multiple procedure suites in the Jacksonville area often ask that this documentation be filed centrally so that any location can reference it during an audit.
- Donor eligibility and screening summary
- Lot-specific certificate of analysis
- Processing and sterility testing description
- Storage and shelf-life information for the format ordered
Jacksonville
NPPES registry listings, primary taxonomy, retrieved 2026-10-27
226- Pain Medicine
- 125
- Physical Medicine & Rehabilitation
- 101
Account verification tied to an NPI
Opening an account with Precision Biologics requires a valid NPI number, which lines up with how most pain management groups already separate ordering by practice location rather than by individual clinician. Once verified, a practice's designated purchaser can review product documentation and place orders without re-submitting credentials for each request.
Receiving cryopreserved and lyophilized shipments in Northeast Florida
Cryopreserved Wharton's jelly formats ship overnight on dry ice in validated containers and should be checked against the packing slip and lot number on arrival. Lyophilized exosome formats are shelf-stable and do not require the same cold-chain handling, but a receiving log that records the lot number against the certificate of analysis is still useful for a Jacksonville practice tracking product by patient record.
Checking regulatory standing before adding a new product
A pain management practice should confirm its own standing with the Florida Board of Medicine and review any new product category with its own counsel before incorporating it into its service line. Florida's SB 1768, in effect since 2025-07-01, permits physicians to use certain non-FDA-approved stem cell therapies in pain management, orthopedics and wound care under informed consent and disclosure rules, but it operates alongside, not in place of, federal FDA requirements for the product itself. Precision Biologics' team can schedule a documentation-focused peer-to-peer call for a practice's medical director, though these calls do not cover clinical use or indications.
FDA has stated there are no FDA-approved exosome products. Exosome products are generally regulated as biologic drugs under section 351 of the Public Health Service Act, not as 361 HCT/Ps. Purchase and clinical use decisions belong to the physician with their own regulatory counsel.
These products are not FDA approved or licensed for any disease or condition. Information is for licensed healthcare professionals and is not medical or legal advice.
Frequently asked questions
Can a multi-location pain management group in Jacksonville use one account for several sites?+
Account setup is handled case by case; a group with multiple locations should discuss how NPI numbers map to its sites when applying for account verification.
Do lyophilized exosome products need cold storage during transit to Jacksonville?+
No. Lyophilized formats are described by the supplier as shelf-stable under normal storage, unlike cryopreserved Wharton's jelly formats, which ship on dry ice.
Where can we verify FDA status of exosome products before purchasing?+
FDA has stated there are no FDA-approved exosome products; practices should review this directly with FDA guidance and their own counsel rather than rely on supplier claims.